ALISO VIEJO, Calif. — Ambry Genetics today introduces their new StemArray™ product and services utilizing aCGH technology to cover the entire genome. The Ambry StemArray™ offers a higher resolution approach to standard karyotyping for stem cells at comparable costs. The 44K array offers increased coverage in known stem cell and cancer associated genes to further […]
Company Provides Guidance for 2010 SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN) today announced revenue for the fourth quarter of 2009 of approximately $176 million based on management’s preliminary review of quarterly financial results. This compares to fourth quarter revenue guidance of a minimum of $165 million and implies fiscal year 2009 revenue of approximately $662 million or […]
Delivers Industry-Proven Infinium® HD Quality at Exceptional Price SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN) today announced the HumanOmniExpress BeadChip (OmniExpress), the newest addition to the Omni family of microarrays for genome-wide association studies (GWAS). Designed as a 12-sample Beadchip, OmniExpress allows interrogation of over 700,000 variants per sample totaling more than eight million available data points on […]
Content Designed in Collaboration with Major Agricultural and Livestock Organizations SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN) announced today the next-generation High-Density Bovine BeadChip (BovineHD) array product using its Infinium® HD assay. The chip contains data from more than 20 diverse breeds that was generated from recent sequencing largely done with Illumina Genome AnalyzerIIx technology. The BovineHD BeadChip […]
Washington, DC — It’s the ultimate goal in the treatment of cancer: tailoring a person’s therapy based on his or her genetic makeup. While a lofty goal, scientists are steadily moving forward, rapidly exploiting new technologies. Researchers at Georgetown Lombardi Comprehensive Cancer Center report a significant advance in this field of research using a new […]
Enhanced Automated Microarray Printing Bandwidth Increases Company’s Competitiveness in the Diagnostics Marketplace SUNNYVALE, Calif. — Arrayit Corporation (OTC Bulletin Board: ARYC), a life sciences and healthcare technology leader, today announced that the Company has made a technological breakthrough in the speed and efficiency by which it manufactures its proprietary microarrays, which are tiny glass substrates […]
FDA Authorizes Emergency Use of Assay for the Detection and Differentiation of the 2009 H1N1 Influenza A Virus SANTA CLARA, Calif. & POTOMAC FALLS, Va.–TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing […]
The Smallest, Most Economic Array Reader on the Market MUKILTEO, Wash., Dec. 16, 2009 — CombiMatrix Corporation (Nasdaq:CBMX) announced today the launch of its next-generation ElectraSense(R) microarray reader. The new ElectraSense(R) provides a robust, affordable, and user-friendly microarray reader that electrochemically measures up to 12,000 probes on an array in less than 25 seconds. The […]
HAMBURG, Germany — Eppendorf has initiated an import ban for Nanosphere, Inc.’s Verigene(R) and Verigene(R) SP systems for infringement of European patent EP 1 179 180 B2, titled “Method for the identification and/or the quantification of a target compound”. The import ban covers any and all imports of the respective products into any country of […]
Louisville, KY — Lynn L’Archeveque has recently joined SCHOTT as the US east coast Sales manager for the Nexterion® range of microarray products. She has a strong technical background in molecular biology, gained through a BA (Biological Sciences) at Mount Holyoke College, and as a research scientist at Exelixis, Inc.. Prior to joining SCHOTT Lynn […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
